Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04868513
Other study ID # Oral health promotion
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 2015
Est. completion date December 2017

Study information

Verified date April 2021
Source Biochemical and Microbiology Laboratory, Faculty of Dentistry, Autonomous University of San Luis Pot
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evidence exists on the vertical transmission of Streptococcus mutans from the mother to her children. This transmission can be prevented by maintaining maternal oral health during pregnancy.


Description:

The aim of this study was to evaluate the enhancing effect of 1% chlorhexidine varnish together with silane fluoride re-mineralizing varnish and oral health promotion strategy on the reduction of S. mutans counts in saliva of pregnant women and the early mother-infant transmission until the first six months of age of the newborn. Methods: An open, random clinical trial of parallel groups was performed. 56 pregnant women free of caries were studied prospectively and longitudinally since the third trimester of gestation until 6 months after giving birth, the newborns were also assessed until reaching 6 months of age. Two groups were formed assigning 28 women to each intervention group. G-I received 0.1% silane fluoride applied as varnish in each visit. G-II women's teeth were coated with 0.1% silane fluoride and 1% chlorhexidine. For the primary culture, CRT Bacteria® system (Ivoclar-Vivadent™) was used for the growth and identification of cariogenic Streptococci. Identification of S. mutans was performed through PCR. The DNA of the isolates identified molecularly as S. mutans was used for a second PCR reaction using the arbitrary primer OPA-O2 to determine the homology among the samples of isolated bacteria from the mother-child pair.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date December 2017
Est. primary completion date October 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Pregnant women in the third trimester with a normal and healthy pregnancy. - Ages ranged from 18 to 45 years - Free of caries (if caries were present, they were treated before enrolling them in the study). Exclusion Criteria: -Non-pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Pregnant women to whom applied silane fluoride
Pregnant women who received 0.1% silane fluoride applied as varnish in the teeth.
Pregnant women to whom applied silane fluoride + 1% chlorhexidine
Pregnant women who received silane fluoride + 1% chlorhexidine applied as varnish in the teeth.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Biochemical and Microbiology Laboratory, Faculty of Dentistry, Autonomous University of San Luis Pot

Outcome

Type Measure Description Time frame Safety issue
Primary Caries prevalence assessment in pregnant womens For this purpose, the Decayed, Missing, and Filled Teeth Index was used to measure the prevalence of caries. This index is based on in-field clinical examination of individuals by using a probe, mirror and cotton rolls, and simply counts the number of decayed, missing (due to caries only) and restored teeth the number of participants with prevalence of caries will be reported. Basal measurement, at the beginning of the third trimester of gestation.
Primary Streptococcus mutans levels identified in pregnant womens In this measurement was identified the S. mutans counts in the saliva of pregnant women after the applications of 1% chlorhexidine varnish together with the application of silane fluoride re-mineralizing varnish or only with the application of silane fluoride, was reported the distribution of cariogenic Streptococcus levels in mothers. Basal measurement, at the beginning of the third trimester of gestation.
Primary Streptococcus mutans levels identified in pregnant womens In this measurement was identified the S. mutans counts in the saliva of pregnant women after the applications of 1% chlorhexidine varnish together with the application of silane fluoride re-mineralizing varnish or only with the application of silane fluoride, was reported the distribution of cariogenic Streptococcus levels in mothers. Three months after the birth of the child.
Primary Streptococcus mutans levels identified in pregnant womens In this measurement was identify the S. mutans counts in the saliva of pregnant women after the applications of 1% chlorhexidine varnish together with the application of silane fluoride re-mineralizing varnish or only with the application of silane fluoride. Will be reported the distribution of cariogenic Streptococcus levels in mothers. Six months after the birth of the child
Primary Genotypes of the isolates of S. mutans in pregnant womens. The genotypes describes an organism's complete set of genes, in this study, was determined the homology among the samples of isolated bacteria from the mother-child pair. The molecular PCR test was implemented for the identification. Will be reported the % of S. mutans genotypes isolated from the mothers of both groups to the strains isolated from the newborns. Three months after the birth of the child.
Primary Streptococcus mutans levels identified in childrens In this measurement was identified the S. mutans counts in the saliva of the children. Will be reported the distribution of cariogenic Streptococcus levels in the children. Three months after the birth of the child.
Primary Streptococcus mutans levels identified in children In this measurement was identified the S. mutans counts in the saliva of the children. Will be reported the distribution of cariogenic Streptococcus levels in the children. Six months after the birth of the child.
Primary Genotypes of the isolates of S. mutans in children. The genotypes describes an organism's complete set of genes, in this study was determined the homology among the samples of isolated bacteria from the mother-child pair, was reported the % of S. mutans genotypes isolated from the children. Three months after the birth of the child.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03955263 - Malaria In Pregnancy in Central India
Not yet recruiting NCT04457947 - Exploring Aromatherapy Intervention in Acute Care
Active, not recruiting NCT01397318 - Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight N/A
Completed NCT00639145 - Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Not yet recruiting NCT00931099 - Fetal Outcome of Sleep Disordered Breathing During Pregnancy N/A
Recruiting NCT00751569 - microRNA Profile in Umbilical Cord Blood NK Cells N/A
Completed NCT06111716 - Mindfulness in Childbirth Preparation Education Process N/A
Completed NCT05729191 - Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
Completed NCT01687634 - Home Visiting for Low Income, Pregnant Women N/A
Recruiting NCT05446571 - Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir Phase 3
Not yet recruiting NCT03651934 - Verification of Correlation Between Genetic Testing of Nutritional Metabolism and Clinical Biochemical Indicators N/A
Active, not recruiting NCT06422130 - Ningbo Maternity-Child Linked Database Study
Completed NCT03538106 - Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
Completed NCT02904473 - Goals for Reaching Optimum Wellness (GROWell) N/A
Recruiting NCT01246765 - National Pregnancy Registry for Psychiatric Medications
Completed NCT00553228 - Pertussis Maternal Immunization Study Phase 2/Phase 3
Recruiting NCT05916534 - We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare N/A
Completed NCT04264910 - CALM Pregnancy: Feasibility of Calm for Pregnant Women N/A
Completed NCT04494581 - GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
Recruiting NCT05349279 - Qatar PREgnancy Covid-19 OUtcome Study